Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2012.01.018
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2017English

Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer

Cureus
2020English

Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival After Stereotactic Body Radiation Therapy for Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2015English

Rib Dose Constraints for Lung Stereotactic Body Radiation Therapy

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2016English

Evaluating Published Skin Dose Tolerance Limits for Stereotactic Body Radiation Therapy of Lung Cancer

Cureus
2012English

Dose Escalation With Stereotactic Body Radiation Therapy Boost for Locally Advanced Non Small Cell Lung Cancer

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2013English

Stereotactic Body Radiation Therapy for Prostate Cancer

Future Oncology
MedicineCancer ResearchOncology
2011English

PS03.03 Salvage Therapy for Relapse After Stereotactic Body Radiation for Stage I Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2017English

Case Series of 23 Patients Who Developed Fatal Radiation Pneumonitis After Stereotactic Body Radiotherapy for Lung Cancer

Technology in Cancer Research and Treatment
MedicineCancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy